‘Weight-loss drugs’ may benefit patients with diabetes, obesity, heart, liver conditions
Major trials link semaglutide to fewer heart attacks and slower kidney decline.…
Willow joins researchers in making the evidence-based case for stronger tobacco taxes
Better coordination, local evidence and sustained public communication will determine whether health…
